University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effect of Raltegravir on Endothelial Function in HIV-Infected Patients

Phase 4

Completed

Conditions: Cardiovascular Disease
HIV Infections
HIV Infection
Inflammation

Interventions: Drug: Placebo
Drug: raltegravir

First Posted Date: 2009-02-13

Last Posted Date: 2018-12-12

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 56

Registration Number: NCT00843713

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

RAD001 and Erlotinib in Patients With Neuroendocrine Tumors

Phase 2

Terminated

Conditions: Neuroendocrine Tumors

Interventions: Drug: RAD001
Drug: erlotinib

First Posted Date: 2009-02-13

Last Posted Date: 2020-09-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 17

Registration Number: NCT00843531

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Resistive/Cardiovascular Training Study

Completed

Conditions: Muscular Atrophy

First Posted Date: 2009-02-03

Last Posted Date: 2011-05-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 36

Registration Number: NCT00835601

Effectiveness of a Behavioral Treatment Program for Attention Deficit Hyperactivity Disorder, Inattentive Type

Not Applicable

Completed

Conditions: Attention Deficit Disorder With Hyperactivity

Interventions: Behavioral: Child Life and Attention Skills (CLAS) Program
Behavioral: Parent Focused Training (PFT)

First Posted Date: 2009-02-03

Last Posted Date: 2019-06-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 199

Registration Number: NCT00834821

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
University of California, Berkeley, Berkeley, California, United States

Community Based Participatory Research With Immigrant Chinese With Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

First Posted Date: 2009-02-02

Last Posted Date: 2013-10-31

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 148

Registration Number: NCT00833677

Locations: 🇺🇸
School of Nursing, University of California, San Francisco, San Francisco, California, United States

Endothelial Function and Vein Graft Remodeling

Completed

Conditions: Peripheral Arterial Disease
Cardiovascular Disease

First Posted Date: 2009-01-28

Last Posted Date: 2022-09-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 55

Registration Number: NCT00831090

Locations: 🇺🇸
San Francisco Veterans Affairs Medical Center, San Francisco, California, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Drug: sunitinib malate
Other: flow cytometry
Other: immunohistochemistry staining method
Other: laboratory biomarker analysis

First Posted Date: 2009-01-16

Last Posted Date: 2018-04-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 13

Registration Number: NCT00824538

Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Glatiramer acetate

First Posted Date: 2009-01-08

Last Posted Date: 2013-10-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 17

Registration Number: NCT00819195

Locations: 🇺🇸
UCSF Multiple Sclerosis Center, San Francisco, California, United States

Effectiveness of a Web-based Prevention Program for Postpartum Depression

Not Applicable

Completed

Conditions: Depression
Postpartum Depression

Interventions: Behavioral: Mothers and babies Internet course and PPD informational brochure

First Posted Date: 2009-01-05

Last Posted Date: 2014-04-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1000

Registration Number: NCT00816725

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Evaluating a Distance Learning Asthma Education Program for Pediatricians (The DALI Study)

Not Applicable

Completed

Conditions: Asthma

Interventions: Behavioral: Distributed Asthma Learning Initiative (DALI) distance learning program

First Posted Date: 2008-12-30

Last Posted Date: 2013-03-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 24

Registration Number: NCT00815724

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy